▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #241 by analyst upside · 2026-06-27
TNON
Tenon Medical, Inc.
Healthcare · Market Cap $6M · P/E 0x
ANALYST PRICE TARGET
+412.7%
implied upside to consensus target
Current Price $0.51
Consensus Target $2.62
Bull Target $3.0
Bear Target $2.25
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $0.35
52-Week High $2.48
YTD Return -47.4%
FUNDAMENTALS
Market Cap $6M
P/E Ratio (TTM) N/A
Forward P/E -0.8x
EPS (TTM) $-1.00
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $5M
Profit Margin -270.1%
52-WEEK RANGE
52-Week Low $0.35
52-Week High $2.48
Current Price $0.51
Bear Target $2.25
Bull Target $3.0
● Now $0.51 ● Target $2.62
TRADING DATA
Avg Volume 5.5M
YTD Return -47.4%
Analyst Count 2
Consensus Strong Buy
Upside to Target +412.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Tenon Medical, Inc. (TNON) is currently trading at $0.51 with a Wall Street consensus price target of $2.62, implying potential upside of 412.7% over the next 12 months. 2 analysts currently cover TNON, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.0, while the most cautious has a target of $2.25.

TNON operates in the Healthcare sector with a market capitalisation of $6M. The stock is down 47.4% year-to-date and is currently trading near the lower end of its 52-week range of $0.35 – $2.48.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

DCOY +400.0%
Decoy Therapeutics Inc.
$3M · P/E 0.1x · Hold
PTN +367.7%
Palatin Technologies, Inc.
$20M · P/E 104.0x · Buy
YCBD +187.7%
cbdMD, Inc.
$7M · P/E 0.3x · Strong Buy
ETST +566.7%
Earth Science Tech, Inc.
$43M · P/E 15.0x · Hold
FBIO +298.6%
Fortress Biotech, Inc.
$92M · P/E 0.9x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for TNON, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Alliance Global Partners ● Initiated
Buy 2025-04-09 14% win rate (7 calls)
Maxim Group — Reiterated
Buy → Buy 2024-11-15 28% win rate (40 calls)
Benchmark reit
Speculative Buy → Speculative Buy 2024-08-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
36
out of 100
Coverage depth
8/30
Consensus clarity
1/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →